Latest news
Selling stockholder to resell 3,571,429 BioStem Technologies (OTC: BSEM) shares - Stock TitanStock Titan · Fri, 07 Aug 2026 21:17:54 GMTBraveheart Bio Shares Begin Nasdaq Trading After $439.9M IPO - Stock TitanStock Titan · Fri, 07 Aug 2026 20:05:00 GMTVir Biotechnology (VIR): State Street discloses 9.96M-share, 5.9% ownership position - Stock TitanStock Titan · Fri, 07 Aug 2026 15:11:21 GMTState Street Corporation (BCRX) discloses 15.2M BioCryst shares in 13G filing - Stock TitanStock Titan · Fri, 07 Aug 2026 12:48:44 GMTPurple Biotech's IM1240 Shows ~8-Fold Longer Half-Life in Preclinical Data - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTZhengye’s closing bid price met Nasdaq’s $1 floor for 10 business days - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTClimb Bio expects CLYM116 Phase 2 dosing to begin in Q3 - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMTBiofrontera schedules Aug. 13 webcast for business update - Stock TitanStock Titan · Wed, 05 Aug 2026 20:15:00 GMT